Latest | F'cast | |
---|---|---|
Div Yield | 1.3% | 0.0% |
Div Cover | 5.3 | 3.9 |
Op Mrgn | 10.0% | 34.8% |
ROCE | 26.3% |
Latest | F'cast | |
---|---|---|
P/E | 14.4 | 14.6 |
PEG | 0.3 | n/a |
Pr/Revenue | 4.1 | 3.9 |
Pr/Book | 2.0 |
Latest | F'cast | |
---|---|---|
Revenue | 67.8% | 5.8% |
PBT | 758.0% | 58.5% |
EPS | 52.5% | -2.4% |
DPS | 66.7% | 33.1% |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-17 | 6.46 | (2.42) | (5.90)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-18 | 14.50 | (0.88) | 17.20p | 26.7 | n/a | n/a | 3.00p | 0.7% |
31-Dec-19 | 33.73 | (0.83) | 35.30p | 17.3 | 0.2 | +105% | 4.50p | 0.7% |
31-Dec-20 | 41.94 | 1.90 | 34.50p | 22.8 | n/a | -2% | 6.00p | 0.8% |
31-Dec-21 | 70.36 | 16.32 | 52.60p | 17.1 | 0.3 | +52% | 10.00p | 1.1% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-22 | 74.43 | 25.87 | 51.36p | 14.7 | n/a | -2% | 13.31p | 0.0% |
31-Dec-23 | 83.91 | 30.84 | 59.15p | 12.8 | 0.8 | +15% | 17.39p | 0.0% |
31-Dec-24 | 93.39 | 36.32 | 66.99p | 11.3 | 0.9 | +13% | 21.70p | 0.0% |
Copyright © 2023 FactSet Research Systems Inc. All rights reserved.
EBT Share Purchase | 30-Jan-2023 | 15:17 | RNS |
Pre-Close Update | 25-Jan-2023 | 07:00 | RNS |
EBT Share Purchase | 23-Jan-2023 | 15:03 | RNS |
Accusations fly as Gresham House battle heats up | 14-Jan-2008 | Times |
Giles Insurance strikes £10m deal with Norwich U... | 25-Sep-2007 | The Herald |
945 given their cards | 15-Dec-2006 | Sun |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 755.00p |
Change Today | -4.00p |
% Change | -0.53 % |
52 Week High | 1,005.00 |
52 Week Low | 710.00 |
Volume | 88,540 |
Shares Issued | 38.27m |
Market Cap | £288.97m |
RiskGrade | 80 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 4 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 6 |
Latest | Previous | |
---|---|---|
Final | Final | |
Ex-Div | 12-May-22 | 06-May-21 |
Paid | 27-May-22 | 21-May-21 |
Amount | 10.00p | 6.00p |
Time | Volume / Share Price |
16:15 | 15,000 @ 754.33p |
16:11 | 394 @ 754.00p |
16:01 | 3 @ 756.99p |
15:59 | 750 @ 757.00p |
15:48 | 1,000 @ 757.00p |
Chair | Anthony Townsend |
CEO | Anthony (Tony) Dalwood |
CFO | Kevin Acton |
You are here: research